Sotorasib for Colorectal Cancer
Study Summary
This trial is testing two doses of a new drug, sotorasib, to see if it can help people with a certain type of colorectal cancer that has come back after treatment.
- Colorectal Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
How many facilities are participating in this clinical trial?
"Currently, there are 16 sites where this trial is recruiting patients. To make things more convenient for patients, these sites are located in major cities such as Lansing, Washington and Columbus."
What are some severe side effects that have been linked to Sotorasib?
"Sotorasib has undergone Phase 3 trials, meaning that there is both evidence of efficacy and multiple rounds of data supporting safety. As such, our team has given it a score of 3 for safety."
Our research indicates that this study is only meant for individuals who are adults, correct?
"The age requirements to participate in this study are that patients must have celebrated their 18th birthday, and not have their 100th birthday."
Are there any available vacancies for potential participants in this research?
"Yes, if you visit clinicaltrials.gov you'll see that this trial is still looking for participants. The trial was created on 4/19/2022 and was updated on 10/12/2022. In total, they need 153 participants from 16 different sites."